Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis

被引:243
作者
Jensen, JM
Fölster-Holst, R
Baranowsky, A
Schunck, M
Winoto-Morbach, S
Neumann, C
Schütze, S
Proksch, E
机构
[1] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany
[2] Univ Kiel, Inst Immunol, Kiel, Germany
关键词
atopic dermatitis; filaggrin; involucrin; keratin; loricrin; sphingomyelinase;
D O I
10.1111/j.0022-202X.2004.22621.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A defective permeability barrier leads to the penetration of environmental allergens into the skin and initiates immunological reactions and inflammation crucially involved in the pathogenesis of atopic dermatitis (AD). Decreased stratum corneum ceramide content may cause the defect in permeability barrier function consistently found in AD. Acid and neutral sphingomyelinase (A- and N-SMase) generate ceramides with structural and signal transduction functions in epidermal proliferation and differentiation. We determined epidermal SMase activities, DNA synthesis, involucrin, loricrin, filaggrin, and keratin expression in lesional and non-lesional skin of AD patients. We found decreased epidermal A-SMase activity in lesional and non-lesional skin, correlating with reduced stratum corneum ceramide content and disturbed barrier function. N-SMase activity was reduced in non-lesional skin and more significantly reduced in lesional skin, correlating with impaired expression of cornified envelope proteins and keratins, important for skin barrier function. Changes in involucrin, loricrin, filaggrin, keratin K 5 (basal) and K 16 (proliferation associated) were noticed in non-lesional and lesional skin, whereas changes in K 10 (suprabasal), K 6 (proliferation associated), and K 17 (inflammation associated) were found only in lesional skin. In summary, reduction in SMase-generating ceramides and impaired differentiation are involved in the defective barrier function found in AD.
引用
收藏
页码:1423 / 1431
页数:9
相关论文
共 79 条
[1]   STUDIES OF THE CLINICALLY UNINVOLVED SKIN IN PATIENTS WITH DERMATITIS [J].
ALJABERI, H ;
MARKS, R .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (04) :437-443
[2]   Stress-induced changes in skin barrier function in healthy women [J].
Altemus, M ;
Rao, B ;
Dhabhar, FS ;
Ding, WH ;
Granstein, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :309-317
[3]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[4]  
BARTH J, 1989, CHRON DERM, V10, P609
[5]   PATHOGENESIS OF ATOPIC ECZEMA [J].
BOS, JD ;
KAPSENBERG, ML ;
SMITT, JHS .
LANCET, 1994, 343 (8909) :1338-1341
[6]   SPHINGOMYELINASE IN PIG AND HUMAN EPIDERMIS [J].
BOWSER, PA ;
GRAY, GM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 70 (06) :331-335
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth [J].
Buisson-Legendre, N ;
Bernard, P ;
Bobichon, H ;
Emonard, H ;
Schneider, C ;
Maquart, FX ;
Haye, B ;
Hornebeck, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) :634-640
[9]  
CLINE PR, 1983, CANCER RES, V43, P3203
[10]   Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci [J].
Cookson, WOCM ;
Ubhi, B ;
Lawrence, R ;
Abecasis, GR ;
Walley, AJ ;
Cox, HE ;
Coleman, R ;
Leaves, NI ;
Trembath, RC ;
Moffatt, MF ;
Harper, JI .
NATURE GENETICS, 2001, 27 (04) :372-373